Taken together, these observations suggest that RIG-I induction in tumor-infiltrating CD8+ T cells of patients with advanced colorectal cancer may promote tumor progression, since elevated RIG-I expression should compromise CD8+ T cells’ survival and cytotoxicity. The gene discussed is RIGI; the disease is colorectal cancer.